← Back to Search

Antiplatelet Agent

30m DAPT Group for Coronary Artery Disease

Phase 4
Waitlist Available
Led By David Kandzari, M.D.
Research Sponsored by Cordis Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Phase I: Enrollment Inclusion Criteria
The subject must be 18 years of age.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

CYPRESS: A Prospective,Randomized,Multi-Center,Double-Blind Trial to Assess the Effectiveness and Safety of Different Durations of Dual Anti-Platelet Therapy (DAPT) in Subjects Undergoing Percutaneous Coronary Intervention with the CYPHER® Sirolimus-eluting Coronary Stent (CYPHER® Stent)

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Phase I: the Rate of Target Lesion Failure (TLF)
Secondary outcome measures
Rate of Academic Research Consortium (ARC) Defined Stent Thrombosis (ST)
Rate of Cardiac Death
Rate of Clinically Driven Target Vessel Revascularization (TVR)
+9 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: 30m DAPT GroupActive Control1 Intervention
Group II: 12m DAPT GroupPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Cordis CorporationLead Sponsor
91 Previous Clinical Trials
121,111 Total Patients Enrolled
49 Trials studying Coronary Artery Disease
76,030 Patients Enrolled for Coronary Artery Disease
David Kandzari, M.D.Principal InvestigatorPiedmont Hospital, Atlanta, GA
Daniel Simon, M.D.Principal InvestigatorUniversity Hospitals, Case Medical Center (Cleveland)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
CYPRESS - CYPHER for Evaluating Sustained Safety
2009. "CYPRESS - CYPHER for Evaluating Sustained Safety". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00954707.
All > Durlaza
~160 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top